Page 104 - Amgen News Today

After taking most of a decade to approve its first interchangeable biosimilar (Semglee (insulin glargine-yfgn), the U.S. Food and Drug Administration has approved three interchangeable...

Appeals from and redacted memorandum and opinion in support of judgment in Regeneron v. Mylan (aflibercept) BPCIA case filed

- CX-904 (EGFRxCD3 T-cell engager) initial Phase 1a dose escalation data in solid tumors anticipated in the 2nd half of 2024 - - CX-2051 (EpCAM ADC) Phase...

Obsidian Personal Planning Solutions LLC bought a new stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 826 shares of the medical research company’s stock, valued at approximately $222,000. Other hedge funds […]

Obsidian Personal Planning Solutions LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) in the third quarter, Holdings Channel reports. The institutional investor bought 826 shares of the medical research company’s stock, valued at approximately $222,000. A number of other institutional investors also recently modified their holdings of the company. OFI Invest […]

A conversation between Colin Weller, VP and GM of the evidence platform at Medable and Liza Laws, senior editor, at Outsourcing Pharma, was held at this year’s SCOPE 2024 in Orlando.

Trust Co. of Vermont lessened its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 10.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,841 shares of the medical research company’s stock after selling 2,682 shares during the period. Trust Co. of Vermont’s holdings […]

Barbara Bouza, the President of Walt Disney Imagineering, will be moving on from her role with The Walt Disney Company. What’s Happening: In a heartfelt post on her Instagram, Bouza talked about her time with Walt Disney Imagineering before revealing that she will be wrapping up her work a

Integrated Advisors Network LLC boosted its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.6% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 13,713 shares of the medical research company’s stock after buying an additional 352 shares during the period. Integrated Advisors Network LLC’s holdings in Amgen were worth $3,685,000 […]

Diversified Trust Co boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 21,319 shares of the medical research company’s stock after purchasing an additional 440 shares during the quarter. Diversified Trust […]